Skip to content

Clinical research on the treatment of degenerative lumbar spondylolisthesis by ''two acupuncture and one moxibustion'' integrated therapy combined with core muscle group training

Clinical research on the treatment of degenerative lumbar spondylolisthesis by ''two acupuncture and one moxibustion'' integrated therapy combined with core muscle group training

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005235
Enrollment
Unknown
Registered
2021-08-27
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

degenerative lumbar spondylolisthesis

Interventions

Sponsors

The First Affiliated Hospital of He'nan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the DLS diagnostic criteria of 1° degenerative lumbar spondylolisthesis (posterior spondylolisthesis); 2. Enrollment age is greater than 50 years old and less than 75 years old; 3. The course of the disease is less than 2 years; 4. Those who have not taken psychotropic drugs before joining the group; 5. Subjects who have not received Chinese and Western medicines for the treatment of degenerative lumbar spondylolisthesis 2 months before enrollment; 6. There are no pathological features that affect the results of this subject, such as history of severe lumbar spine trauma, tuberculosis, tumors, fractures, moderate to severe osteoporosis and other lumbar spine bone destruction; 7. Those who voluntarily participate in this research, sign the informed consent form, and cooperate with the subjects of this subject.

Exclusion criteria

Exclusion criteria: 1. Low back pain accompanied by severe sensory and motor abnormalities of both lower extremities, spinal cord compression or obvious symptoms of nerve root injury; 2. Those with severe blood disease, hypertension, diabetes and endocrine system diseases; 3. Patients with mental disorders or patients who cannot cooperate with the test; 4. Combination medication or participating in other trials during treatment.

Design outcomes

Primary

MeasureTime frame
Japanese Orthopedic Association Score;

Secondary

MeasureTime frame
Visual Analogue Scale;Gait Analysis;Oswestry Disability Index;Surface Electromyography;

Countries

China

Contacts

Public ContactSong Xiaolei
46716852@qq.com+86 13783472087

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026